Jeffrey Guss

Jeffrey Guss is a psychiatrist, psychoanalyst, and researcher with a specialization in the treatment of substance use disorders. He is a clinical assistant professor of psychiatry at the NYU School of Medicine.

CV

Jeffrey Guss was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psilocybin-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psilocybin-assisted therapy for Major Depressive Disorder, and a study therapist with the MAPS study on treatment of Post Traumatic Stress Disorder with MDMA-Assisted Psychotherapy.

He is an instructor and mentor with the California Institute of Integral Studies’ (CIIS) Center for Psychedelic Therapies and Mentor in NYU’s Fellowship in Addiction Psychiatry. He maintains a private practice in New York City.

Notable Research Papers

• Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (Ross et al., 2016)
• Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer (Agin-Liebes et al., 2020)
• Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame (Sloshower et al., 2020)

Find more on Google Scholar or PubMed

In our database you will also find him as an author on more papers.

Media

• Antianxiety and antidepressant effects from a single dose of psychedelic drug persist years later in cancer patients (Science Daily, January 2020)
• Jeffrey Guss: Psychedelic Therapy for Depression using Acceptance and Commitment Therapy (Colloquium on Psychedelic Psychiatry, 2018)
• Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer (EurekAlert, December 2016)
• Psilocybin-Assisted Therapy for Cancer Patients – Jeffrey Guss (ICPR, 2016)
• Horizons 2010: JEFFREY GUSS MD “The NYU Psilocybin Cancer Anxiety Research Project’s Psychedelic…” (Horizons, 2010)